老年糖尿病的流行病学特点

doi:10.3969/j.issn.1003-9198.2022.10.001

摘要/Abstract

中图分类号:

R587.1

祖丽胡玛尔·阿布都艾尼, 刘超. 老年糖尿病的流行病学特点[J]. 实用老年医学, 2022, 36(10): 973-977.

[1] SUN H, SAEEDI P, KARURANGA S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183: 109-119.
[2] LEROITH D, BIESSELS G J, BRAITHWAITE S S, et al. Treatment of diabetes in older adults: an endocrine society clinical practice guideline[J]. J Clin Endocrinol, 2019, 104(5): 1520-1574.
[3] RASOOLY R S, AKOLKAR B, SPAIN L M, et al. The national institute of diabetes and digestive and kidney diseases central repositories: a valuable resource for nephrology research[J]. Clin J Am Soc Nephrol, 2015, 10(4): 710-715.
[4] LIU J L, REN Z H, QIANG H, et al. Trends in the incidence of diabetes mellitus: results from the global burden of disease study 2017 and implications for diabetes mellitus prevention[J]. BMC Public Health, 2020, 20(1): 1415.
[5] LI Y, TENG D I, SHI X, et al. Prevalence of diabetes recorded in mainland china using 2018 diagnostic criteria from the American diabetes association: national cross sectional study[J]. Brit Med J, 2020, 369:m997.
[6] International diabetes federation. IDF diabetes atlas 8th edition[R/OL]. [2022-07-02] . https://diabetesatlas.org/upload/resources/previous/files/8/IDF_DA_8e-EN-final.pdf.
[7] SU B B, WANG Y R, DONG Y H, et al. Trends in diabetes mortality in urban and rural China, 1987-2019: a joinpoint regression analysis[J]. Front Endocrinol, 2021, 12: 777654.
[8] SCHILLINGER D, GRUMBACH K, PIETTE J, et al. Association of health literacy with diabetes outcomes[J]. JAMA, 2002, 288(4): 475-482.
[9] PADRÓS G, FERRER A, FORMIGA F, et al. Prevalence of prediabetes and associated factors in the oldest old: a cross sectional study in the octabaix cohort[J]. Int J Gerontol, 2017, 11(2): 90-94.
[10] SOBERS-GRANNUM N, MURPHY M M, NIELSEN A, et al. Female gender is a social determinant of diabetes in the Caribbean: a systematic review and meta-analysis[J]. PLoS One, 2015, 10(5): e0126799.
[11] CHIA C W, EGAN J M, FERRUCCI L. Age-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk[J]. Circ Res, 2018, 123(7): 886-904.
[12] LI N, LIU F, YANG P, et al. Aging and stress induced β cell senescence and its implication in diabetes development[J]. Aging, 2019, 11(21): 9947-9959.
[13] ALHAZMI A, STOJANOVSKI E, MCEVOY M, et al. Macronutrient intakes and development of type 2 diabetes: a systematic review and meta-analysis of cohort studies[J]. J Am Coll Nutr, 2012, 31(4): 243-258.
[14] YU D M, ZHAO L Y, ZHANG J, et al. China nutrition and health surveys (1982-2017)[J]. China CDC Weekly, 2021, 3(9): 193.
[15] LEE I M, SHIROMA E J, LOBELO F, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy[J]. Lancet, 2012, 380(9838): 219-229.
[16] BELLETTIERE J, HEALY G N, LAMONTE M J, et al. Sedentary behavior and prevalent diabetes in 6166 older women: the objective physical activity and cardiovascular health study[J]. J Gerontol A Biol Sci Med Sci, 2019, 74(3): 387-395.
[17] PAN A, WANG Y, TALAEI M, et al. Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis[J]. Lancet Diabetes Endo, 2015, 3(12): 958-967.
[18] WILLI C, BODENMANN P, GHALI W A, et al. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis[J]. JAMA, 2007, 298(22): 2654-2664.
[19] KAWAKAMI N, TAKATSUKA N, SHIMIZU H, et al. Effects of smoking on the incidence of non-lnsulin-dependent diabetes mellitus. Replication and extension in a Japanese cohort of male employees[J]. Am J Epidemiol, 1997, 145(2): 103-109.
[20] PENG K, CHEN G, LIU C, et al. Association between smoking and glycemic control in diabetic patients: results from the risk evaluation of cancers in Chinese diabetic individuals[J]. J Diabetes, 2018, 10(5): 408-418.
[21] HOLST C, BECKER U, JØRGENSEN M E, et al. Alcohol drinking patterns and risk of diabetes: a cohort study of 70551 men and women from the general Danish population[J]. Diabetologia, 2017, 60(10): 1941-1950.
[22] DJOUSSÉ L, BIGGS M L, MUKAMAL K J, et al. Alcohol consumption and type 2 diabetes among older adults: the cardiovascular health study[J]. Obesity, 2007, 15(7): 1758-1765.
[23] KIM S J, KIM D J. Alcoholism and diabetes mellitus[J]. Diabetes Metab J, 2012, 36(2): 108-115.
[24] RESNICK H E, REDLINE S, SHAHAR E, et al. Diabetes and sleep disturbances: findings from the sleep heart health study[J]. Diabetes Care, 2003, 26(3): 702-709.
[25] MOSAVAT M, MIRSANJARI M, ARABIAT D, et al. The role of sleep curtailment on leptin levels in obesity and diabetes mellitus[J]. Obes Facts, 2021, 14(2): 214-221.
[26] ACOSTA-RODRI＇GUEZ V A, RIJO-FERREIRA F, GREEN C B, et al. Importance of circadian timing for aging and longevity[J]. Nat Commun, 2021, 12(1): 1-12.
[27] OLAFSDOTTIR E, ASPELUND T, SIGURDSSON G, et al. Unfavourable risk factors for type 2 diabetes mellitus are already apparent more than a decade before onset in a population-based study of older persons[J]. Eur J Epidemiol, 2009, 24(6): 307-314.
[28] PETRIE J R, GUZIK T J, TOUYZ R M. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms[J]. Can J Cardiol, 2018, 34(5): 575-584.
[29] WANG F, HAN L, HU D. Fasting insulin, insulin resistance and risk of hypertension in the general population: a meta-analysis[J]. Clin Chim Acta, 2017, 464: 57-63.
[30] EMDIN C A, ANDERSON S G, WOODWARD M, et al. Usual blood pressure and risk of new-onset diabetes: evidence from 4.1 million adults and a meta-analysis of prospective studies[J]. J Am Coll Cardiol, 2015, 66(14): 1552-1562.
[31] ZHANG R, CAI X L, LIU L, et al. Type 1 diabetes induced by immune checkpoint inhibitors[J]. Chin Med J, 2020, 133(21): 2595-2598.
[32] BLACKBURN D, HUX J, MAMDANI M. Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly[J]. J Gen Intern Med, 2002, 17(7):17-20.
[33] RIDKER P M, PRADHAN A, MACFADYEN J G, et al. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial[J]. Lancet, 2012, 380(9841): 565-571.
[34] LEE S E, SUNG J M, CHO I J, et al. Risk of new-onset diabetes among patients treated with statins according to hypertension and gender: results from a nationwide health-screening cohort[J]. PLoS One, 2018, 13(4): e0195459.
[35] WATERS D D, HO J E, DEMICCO D A, et al. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials[J]. J Am Coll Cardiol, 2011, 57(14): 1535-1545.
[36] CAPEAU J, BOUTELOUP V, KATLAMA C, et al. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment[J]. Aids, 2012, 26(3): 303-314.
[37] RUBIN R R, MA Y, PEYROT M, et al. Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study[J]. Diabetes care, 2010, 33(12): 2549-2551.
[38] ANDERSOHN F, SCHADE R, SUISSA S, et al. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus[J]. Am J Psychiat, 2009, 166(5): 591-598.
[39] DERIJKS H J, MEYBOOM R H B, HEERDINK E R, et al. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports[J]. Eur J Clin Pharmacol, 2008, 64(5): 531-538.

老年糖尿病的流行病学特点

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	张星星, 张海洋, 何小菁, 鲁翔. 不同肥胖指标与老年人糖尿病患病风险的调查研究[J]. 实用老年医学, 2024, 38(9): 940-943.
[2]	赵玉玲, 黄婧, 叶文春. 血清γ-氨基丁酸、胰岛素样生长因子-1对老年糖尿病前期病人心血管事件风险的交互作用分析[J]. 实用老年医学, 2024, 38(8): 816-820.
[3]	梁杉杉, 梁欢, 杨珊, 刘建凤. 老年T2DM病人肌少症发生与颈动脉粥样硬化的相关性研究[J]. 实用老年医学, 2024, 38(8): 826-830.
[4]	时雯, 朱平, 周洁, 颜婷, 黄玉杰, 严妍. 胰激肽原酶治疗老年2型糖尿病轻度认知功能障碍的疗效观察[J]. 实用老年医学, 2024, 38(6): 587-591.
[5]	郭淳, 易梦廷, 宗前兴, 周怡, 巫海娣, 莫永珍. 老年2型糖尿病病人6个月内低血糖风险预测模型的构建:一项纵向研究[J]. 实用老年医学, 2024, 38(6): 592-597.
[6]	包海童, 谈萍, 俞沛文, 刘娟, 丁国宪, 佟蔷薇, 王晓东. 基于老年综合评估的2型糖尿病病人衰弱影响因素分析[J]. 实用老年医学, 2022, 36(12): 1264-1268.
[7]	陈明珠, 许勤, 蔡英华. 老年糖尿病合并衰弱病人自我感受负担的现状及影响因素分析[J]. 实用老年医学, 2022, 36(12): 1269-1272.
[8]	唐伟, 张子成. 老年糖尿病血糖监测技术新进展[J]. 实用老年医学, 2022, 36(10): 978-982.
[9]	徐千越, 胡云. 注射类降糖药物在老年糖尿病病人中的使用新进展[J]. 实用老年医学, 2022, 36(10): 983-985.
[10]	叶德梅, 张俊, 殷汉, 李玲. 老年糖尿病口服降糖药物新进展[J]. 实用老年医学, 2022, 36(10): 986-990.
[11]	李盖, 王雷, 孙新娟, 王天元, 陈金安. 老年2型糖尿病并发症的治疗新进展[J]. 实用老年医学, 2022, 36(10): 991-995.
[12]	俞匀, 唐伟, 娄青林. 不同发病年龄新诊断2型糖尿病病人临床特点分析[J]. 实用老年医学, 2022, 36(10): 1015-1018.
[13]	姚铸玲, 王志勇, 熊亚晴, 徐斐. 南京市老年人群高血压合并糖尿病的流行特征[J]. 实用老年医学, 2022, 36(8): 796-800.
[14]	包宇航, 郑仁东. 糖代谢与睾酮关系的研究进展[J]. 实用老年医学, 2022, 36(8): 850-853.
[15]	仰孝群, 欧阳晓俊. 糖尿病与衰弱相关研究进展[J]. 实用老年医学, 2022, 36(7): 655-659.